Vegzelma Prices, Coupons, Copay Cards & Patient Assistance
Vegzelma (bevacizumab) is a member of the VEGF/VEGFR inhibitors drug class and is commonly used for Cervical Cancer, Colorectal Cancer, Fallopian Tube Cancer, and others.
The cost for Vegzelma (adcd 25 mg/mL) intravenous solution is around $723 for a supply of 4 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Vegzelma prices
Intravenous Solution
adcd 25 mg/mL
Vegzelma intravenous solution
from $722.80
for 4 milliliters
Quantity | Per unit | Price |
---|---|---|
4 milliliters | $180.70 | $722.80 |
16 milliliters | $178.92 | $2,862.71 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Vegzelma Coupons, Copay Cards and Rebates
Vegzelma offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Vegzelma Celltrion Cares Co-Pay Assistance Program
Eligible commercially insured patients may pay $0 per prescription with a savings of $25,000 per calendar year.
- Applies to:
- Vegzelma
- Number of uses:
- Per prescription per calendar year
Form more information phone: 877-812-6662 or Visit website
Patient Assistance & Copay Programs for Vegzelma
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance.Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Vegzelma (bevacizumab-adcd) Injection; IV
More information please phone: 866-316-7263 Visit Website
Provider: Celltrion CONNECT: Vegzelma Patient Support Program
Eligibility requirements:- Uninsured or Underinsured with no prescription coverage for needed medication
- At or below 500% of FPL
- FDA-approved diagnosis
- Must be treated in the US or Puerto Rico
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Vegzelma (bevacizumab-adcd) Injection; IV
More information please phone: 877-812-6662 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Vegzelma (bevacizumab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Patient resources
- Vegzelma drug information
- Vegzelma (Bevacizumab Intravenous) (Advanced Reading)
- Vegzelma (Bevacizumab-adcd Intravenous) (Advanced Reading)
Other brands
Avastin, Zirabev, Mvasi, Alymsys, Avzivi
Professional resources
Other brands
Avastin, Zirabev, Mvasi, Alymsys